Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute of Diabetes Gerhardt Katsch (IDK) is a specialized research organization based in Karlsburg, Germany, dedicated to the study and treatment of diabetes mellitus. Established in 1930, it is one of the oldest and most respected diabetes research centers in Europe, focusing on clinical research, experimental pathophysiology, and medical technology. The institute functions as a Clinical Research Organization (CRO), conducting Phase I through IV clinical trials for global pharmaceutical and biotech partners. Its core expertise includes the development of insulin therapy protocols, glucose sensor technology, and the investigation of diabetic complications. IDK maintains strong academic ties with the University of Greifswald and works closely with the neighboring Karlsburg Clinic to bridge the gap between laboratory research and patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute of Diabetes Gerhardt Katsch.